Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Accumulated Expenses of $640265.0 for Q1 2026, up 62.78% year-over-year from $393342.0 in Q1 2025, and little changed quarter-over-quarter from $642754.0 in Q4 2025.
Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026) Analysis & Trends
Nexalin Technology's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $640265.0 for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 62.78% year-over-year to $640265.0; the TTM figure through Mar 2026 stood at $640265.0 (up 62.78% YoY), while the FY2025 annual figure was $642754.0, up 64.49% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $640265.0, roughly flat from $642754.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $642754.0 in Q4 2025, with the low at $124966.0 in Q2 2024.
- The 5-year median for Accumulated Expenses is $393342.0 (2025), against an average of $425497.2.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses plunged 79.3% in 2024, then soared 188.08% in 2025.
- Nexalin Technology's Accumulated Expenses stood at $539822.0 in 2022, then tumbled by 51.6% to $261284.0 in 2023, then soared by 49.55% to $390745.0 in 2024, then soared by 64.49% to $642754.0 in 2025, then fell by 0.39% to $640265.0 in 2026.
- Business Quant data shows NXL's Accumulated Expenses at $640265.0 in Q1 2026, $642754.0 in Q4 2025, and $290031.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 858,504.00 |
| Mar 31, 2026 | 640,265.00 |
| Dec 31, 2025 | 642,754.00 |
| Sep 30, 2025 | 290,031.00 |
| Jun 30, 2025 | 360,004.00 |
| Mar 31, 2025 | 393,342.00 |
| Dec 31, 2024 | 390,745.00 |
| Sep 30, 2024 | 132,847.00 |
| Jun 30, 2024 | 124,966.00 |
| Mar 31, 2024 | 355,713.00 |
| Dec 31, 2023 | 261,284.00 |
| Sep 30, 2023 | 606,891.00 |
| Jun 30, 2023 | 603,633.00 |
| Mar 31, 2023 | 597,660.00 |
| Dec 31, 2022 | 539,822.00 |
| Sep 30, 2022 | 442,501.00 |
| Dec 31, 2021 | 611,795.00 |